← All organizations
Highest phase reached
Phase 3
First clinical trial
May 5, 2022Last known activity
Jun 22, 2023
Acquired by Alumis Inc on May 1, 2025
Timeline
2020s
- May 1, 2025
Alumis Inc— Acquired By
Drugs by trial phase (2 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (9)
- NCT05905783Study directorPhase 3Jun 22, 2023
- NCT05905783Lead sponsorPhase 3Jun 22, 2023
- NCT05683496Lead sponsorPhase 1/Phase 2Feb 14, 2023
- NCT05623345Lead sponsorPhase 2/Phase 3Nov 21, 2022
- NCT05623345Study directorPhase 2/Phase 3Nov 21, 2022
- NCT05384249Lead sponsorPhase 2Aug 23, 2022
- NCT05384249Study directorPhase 2Aug 23, 2022
- NCT05355805Lead sponsorPhase 2May 5, 2022
- NCT05355805Study directorPhase 2May 5, 2022
Details
- Founded
- Los Angeles, CA, US
- Last known activity
- Jun 22, 2023